This document provides interim guidance for clinicians, laboratories, health workers, public health officials and
other stakeholders involved in the diagnosis and care of patients with suspected or confirmed mpox. This is an updated version of the interim guidance on Laboratory testing for the monkeypox ...
Ebola and Marburg disease outbreaks remain important public health threats. The newly published WHO Infection prevention and control guideline for Ebola and Marburg disease contains the Organization's most up to date recommendations for IPC measures to be implemented in all health facilities when caring ...
Complementary feeding, defined as the
process of providing foods in addition to
milk when breast milk or milk formula
alone are no longer adequate to meet
nutritional requirements, generally starts
at age 6 months and continues until
23 months of age, although breastfeeding
may continue beyond this perio...
Over 45.4 million infants and children under 5 years of age experience wasting each year. The risk of
wasting and nutritional oedema in infants and children, particularly in high-risk contexts where health
and socioeconomic indicators are at their poorest, is heightened by ongoing crises including climat...
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...
Inhibidores de las Cinasas Janus/uso terapéutico,
COVID-19/tratamiento farmacológico,
Antivirales/uso terapéutico,
Ivermectina/uso terapéutico,
Hidroxicloroquina/uso terapéutico,
Plasma/inmunología,
Fluvoxamina/uso terapéutico,
Colchicina/uso terapéutico,
Inmunización Pasiva,
Receptores de Interleucina-6/uso terapéutico,
Lopinavir/uso terapéutico,
Corticoesteroides/uso terapéutico
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is impor...
COVID-19/complicaciones,
COVID-19/diagnóstico,
Máscaras,
Salud Global,
Hospitalización,
Respiración Artificial,
Choque Séptico,
Lactancia Materna,
Embarazo,
Síndrome de Dificultad Respiratoria/etiología,
Neumonía Viral/etiología,
Cuidados Paliativos,
Rehabilitación,
Manejo de Atención al Paciente/organización & administración
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released in 2018 ...
A global shortage of an estimated 18 million health workers is anticipated by 2030, a record 130 million people are in need of humanitarian assistance, and there is the global threat of pandemics such as COVID-19. At least 400 million people worldwide lack access to the most essential health services, an...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with Leis...
This guideline provides locally adaptable, clear, evidence-informed global recommendations on the fortification of wheat flour with vitamins and minerals as a public health strategy to improve the micronutrient status of populations, which are grounded in gender, equity and human rights approaches with t...
